Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8735330 | Hepatobiliary & Pancreatic Diseases International | 2017 | 6 Pages |
Abstract
Emodin alleviated pancreatic and intestinal mucosa injury in experimental SAP. Its mechanism may partly be mediated by the inhibition of caspase-1 and its downstream inflammatory cytokines, including IL-1β and IL-18. Our animal data may be applicable in clinical practice.
Related Topics
Health Sciences
Medicine and Dentistry
Hepatology
Authors
Jian-Wen Ning, Yan Zhang, Mo-Sang Yu, Meng-Li Gu, Jia Xu, Ali Usman, Feng Ji,